Building upon these observations, the present study seeks to comprehensively investigate the functional role and underlying mechanisms of ELOVL2 in enzalutamide resistance in PCa, which aiming to provide novel insights into overcoming therapeutic resistance in advanced PCa. This evidence concerns the gene ELOVL2 and posterior cortical atrophy.